Characterization of the Intronic Splicing Silencers Flanking FGFR2 Exon IIIb

This publication has 51 references indexed in Scilit:

• Restoration of fibroblast growth factor receptor2 suppresses growth and tumorigenicity of malignant human prostate carcinoma PC‐3 cells
  The Prostate, 2004
• Requirement for fibroblast growth factor 10 or fibroblast growth factor receptor 2-IIIb signaling for cecal development in mouse
  Developmental Biology, 2003
• A splicing switch and gain-of-function mutation in FgfR2-IIIc hemizygotes causes Apert/Pfeiffer-syndrome-like phenotypes
  Proceedings of the National Academy of Sciences, 2001
• Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome
  Proceedings of the National Academy of Sciences, 2000
• De Novo Alu-Element Insertions in FGFR2 Identify a Distinct Pathological Basis for Apert Syndrome
  American Journal of Human Genetics, 1999
• Alternative splicing of fibroblast growth factor receptor 2 (FGF-R2) in human prostate cancer
  Oncogene, 1997
• The Heparan Sulfate–Fibroblast Growth Factor Family: Diversity of Structure and Function
  Progress in Nucleic Acid Research and Molecular Biology, 1997
• Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy.
  Molecular and Cellular Biology, 1993
• Developmental Localization of the Splicing Alternatives of Fibroblast Growth Factor Receptor-2 (FGFR2)
  Developmental Biology, 1993
• Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene.
  Proceedings of the National Academy of Sciences, 1992